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May 20121544 AbstractsIntroduction and objectives: Infrainguinal bypass surgery (BPG) is
accompanied by significant 30-day mortality and morbidity, including early
graft failure. The goal of this study is to identify patient- and procedure-
specific factors which predict the rate of early graft failure in contemporary
practice.
Methods: Data was obtained from the private sector National Surgical
Quality Improvement Program, a prospective, validated database collected
between 2005 and 2008 from 211 hospitals, using primary and modifier
Current Procedural Terminology codes for BPG. The primary endpoint was
graft failure at 30 days. Procedural parameters, patient demographics and
clinical variables were analyzed by univariate and multivariate methods.
Results: There were 9217 BPG procedures (limb salvage, 49%; infr-
apopliteal distal anastomosis, 43%; prosthetic 32%) with patient variables:
age 67  12 years, male 64%, diabetes 44%, dialysis 7.4%. Mortality was
2.4%, major morbidity was 17.3%, and graft failure rate was 6.3% at 30 days.
Multivariate predictors of graft failure demonstrated correlation (p-value,
OR) with female gender (p  0.0054, 1.29), limb salvage indication
(p  0.0001, 1.60), infrapopliteal anastomosis (p  0.0001, 2.15), com-
posite graft (p  0.0436, 1.82), current smoking (p  0.0007, 1.36), im-
paired sensorium (p  0.0075, 2.13), emergency procedure (p  0.0001,
2.03), previous vascular procedure (p  0.0005, 1.39), and platelets
400K (p  0.0019, 1.49). High-risk composite constructs utilizing these
significant predictive factors can identify cohorts of patients with up to a
98-fold increase in odds of early graft failure.
Conclusions: These results describe common risk factors that correlate
with early graft thrombosis including the unique description of its associa-
tion with thrombocytosis. Additional risk factors thus identify a subset of
patients who are at highest risk for early BPG failure. This data may be used
to refine patient selection.
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Objectives: Quantify endovenous laser ablation (EVLA) with concur-
ent phlebectomies and ultrasound-guided foam sclerotherapy (UGFS) in
ost and effectiveness at 3 weeks and 3 months.
Design: Single-centre, prospective, randomised controlled trial.
Patients: One hundred patients (100 legs), C2–6, age 21–78, M:F
2:58, with primary varicose veins received either EVLA under local anaes-
hetic or UGFS.
Methods Assessments included duplex, Aberdeen varicose vein ques-
ionnaire (AVVQ), venous clinical severity score (VCSS), venous filling
ndex (VFI), visual analogue 7-day pain score and analgesia requirements.
dditional treatments with UGFS were performed, if required. Micro-
osting, using individually timed treatments, was based on consumables,
taff pay and overheads.
Results: Changes in AVVQ, VCSS and VFI values (3 months) did not
emonstrate any significant difference between groups. At 3 months, the
bove-knee GSV occlusion rate (without co-existing reflux) was not signif-
cantly different between the groups (74% vs 69%; EVLA vs UGFS;
 .596). Of the 9 haemodynamic failures in each group, 7 EVLA patients
nd 4 UGFS patients had co-existing cross-sectional above-knee GSV oc-
lusion at some point. However, UGFS significantly outperformed EVLA in
ost, treatment duration, pain, analgesia requirements and recovery.
Conclusions: UGFS is 3.15 times less expensive than EVLA (£230.24
s £724.72) with comparable effectiveness but 56% (versus 6%) required
dditional foam (ISRCTN:03080206).
